Evidence map›Paper›PMID 22996691›Full record

ArticleThe Journal of clinical investigation2012

Myocardin regulates BMP10 expression and is required for heart development.

Jianhe Huang, John Elicker, Nina Bowens, Xi Liu, Lan Cheng, Thomas P Cappola, Xiaohong Zhu, Michael S Parmacek

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 109 citations in OpenAlex.

  1. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  2. Diagnostic and prognostic utility of bone morphogenetic protein 10 in acute dyspnea: a cohort study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Discovery ofAmerican journal of translational research · 2024
    Article
  14. Article
  15. Identification ofDiagnostics (Basel, Switzerland) · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Direct reprogramming as a route to cardiac repair.Seminars in cell & developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jianhe HuangUniversity of Pennsylvania, Cardiovascular Institute, Department of Medicine, Philadelphia, PA 19104-5159, USA.
John Elicker
Nina Bowens
Xi Liu
Lan Cheng
Thomas P Cappola
Xiaohong Zhu
Michael S Parmacek
University of Pennsylvania · USCardiovascular Institute of the South · US

Funding

Genomics of myocardial transcription factors in cardiac remodelingR01HL088577 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CAPPOLA, THOMAS P. · 2007 to 2013
$5.3M
Myocardin Related Transcription Factor Function in the VasculatureR01HL102968 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PARMACEK, MICHAEL S · 2010 to 2013
$1.8M
Molecular Basis of Myocardin Function in the HeartR01HL094520 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PARMACEK, MICHAEL S · 2009 to 2010
$901k
NHLBI NIH HHS R01 HL088577NHLBI NIH HHS R01 HL094520NHLBI NIH HHS R01-HL094520NHLBI NIH HHS R01 HL102968NHLBI NIH HHS R01-HL102968
6 · The paper itself

Abstract

Myocardin is a muscle lineage-restricted transcriptional coactivator that has been shown to transduce extracellular signals to the nucleus required for SMC differentiation. We now report the discovery of a myocardin/BMP10 (where BMP10 indicates bone morphogenetic protein 10) signaling pathway required for cardiac growth, chamber maturation, and embryonic survival. Myocardin-null (Myocd) embryos and embryos harboring a cardiomyocyte-restricted mutation in the Myocd gene exhibited myocardial hypoplasia, defective atrial and ventricular chamber maturation, heart failure, and embryonic lethality. Cardiac hypoplasia was caused by decreased cardiomyocyte proliferation accompanied by a dramatic increase in programmed cell death. Defective chamber maturation and the block in cardiomyocyte proliferation were caused in part by a block in BMP10 signaling. Myocardin transactivated the Bmp10 gene via binding of a serum response factor-myocardin protein complex to a nonconsensus CArG element in the Bmp10 promoter. Expression of p57kip2, a BMP10-regulated cyclin-dependent kinase inhibitor, was induced in Myocd-/- hearts, while BMP10-activated cardiogenic transcription factors, including NKX2.5 and MEF2c, were repressed. Remarkably, when embryonic Myocd-/- hearts were cultured ex vivo in BMP10-conditioned medium, the defects in cardiomyocyte proliferation and p57kip2 expression were rescued. Taken together, these data identify a heretofore undescribed myocardin/BMP10 signaling pathway that regulates cardiomyocyte proliferation and apoptosis in the embryonic heart.

Indexed as

AnimalsApoptosisBone Morphogenetic ProteinsCell DifferentiationCulture Media, ConditionedFetal HeartGene Expression Regulation, DevelopmentalHeart Defects, CongenitalMiceMice, Inbred BALB CMice, KnockoutMice, TransgenicMyocardinMyocytes, CardiacNuclear ProteinsOrgan Culture TechniquesBmp10 protein, mouseBone Morphogenetic ProteinsCulture Media, ConditionedMyocardinNuclear ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID22996691
PMCPMC3461917
OpenAlexW2063115714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.